BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 23760735)

  • 1. Landiolol: a review of its use in intraoperative and postoperative tachyarrhythmias.
    Plosker GL
    Drugs; 2013 Jun; 73(9):959-77. PubMed ID: 23760735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Landiolol: A Review in Tachyarrhythmias.
    Syed YY
    Drugs; 2018 Mar; 78(3):377-388. PubMed ID: 29470800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of landiolol, an ultra-short-acting β1-selective antagonist, for treatment of sepsis-related tachyarrhythmia (J-Land 3S): a multicentre, open-label, randomised controlled trial.
    Kakihana Y; Nishida O; Taniguchi T; Okajima M; Morimatsu H; Ogura H; Yamada Y; Nagano T; Morishima E; Matsuda N;
    Lancet Respir Med; 2020 Sep; 8(9):863-872. PubMed ID: 32243865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effectiveness and safety of landiolol hydrochloride, an ultra-short-acting β1-blocker, in postoperative patients with supraventricular tachyarrhythmias: a multicenter, randomized, double-blind, placebo-controlled study.
    Taenaka N; Kikawa S
    Am J Cardiovasc Drugs; 2013 Oct; 13(5):353-64. PubMed ID: 23818039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of landiolol hydrochloride on intractable tachyarrhythmia after pediatric cardiac surgery.
    Tokunaga C; Hiramatsu Y; Kanemoto S; Takahashi-Igari M; Abe M; Horigome H; Sakakibara Y
    Ann Thorac Surg; 2013 May; 95(5):1685-8. PubMed ID: 23506630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Landiolol in the treatment of the intraoperative supraventricular tachycardia: a multicenter, randomized, double-blind, placebo-controlled study.
    Xiao J; He P; Zou Q; Zhao Y; Xue Z; Deng X; Li S; Guo Q; Tao G; Yang T; Lang Z; He J; Wang X
    J Clin Anesth; 2015 Mar; 27(2):120-8. PubMed ID: 25434501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Landiolol, an ultra-short-acting β₁-blocker, more effectively terminates atrial fibrillation than diltiazem after open heart surgery: prospective, multicenter, randomized, open-label study (JL-KNIGHT study).
    Sakamoto A; Kitakaze M; Takamoto S; Namiki A; Kasanuki H; Hosoda S;
    Circ J; 2012; 76(5):1097-101. PubMed ID: 22361918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the Therapeutic Efficacy and Safety of Landiolol Hydrochloride for Management of Arrhythmia in Critical Settings: Review of the Literature.
    Matsuishi Y; Mathis BJ; Shimojo N; Kawano S; Inoue Y
    Vasc Health Risk Manag; 2020; 16():111-123. PubMed ID: 32308404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting or cardiac valve surgery: intraoperative use of landiolol.
    Nakanishi K; Takeda S; Kim C; Kohda S; Sakamoto A
    J Cardiothorac Surg; 2013 Jan; 8():19. PubMed ID: 23347432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of landiolol hydrochloride for atrial fibrillation after open heart surgery.
    Nishi H; Sakaguchi T; Miyagawa S; Yoshikawa Y; Fukushima S; Saito S; Ueno T; Kuratani T; Sawa Y
    Heart Vessels; 2013 Jul; 28(4):490-6. PubMed ID: 22661097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study design for control of HEART rate in inFant and child tachyarrhythmia with heart failure Using Landiolol (HEARTFUL): A prospective, multicenter, uncontrolled clinical trial.
    Sumitomo N; Horigome H; Miura M; Ono H; Ueda H; Takigiku K; Yoshimoto J; Ohashi N; Suzuki T; Sagawa K; Ushinohama H; Takahashi K; Miyazaki A; Sakaguchi H; Iwamoto M; Takamuro M; Tokunaga C; Nagano T;
    J Cardiol; 2017 Sep; 70(3):232-237. PubMed ID: 28073682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urgent management of rapid heart rate in patients with atrial fibrillation/flutter and left ventricular dysfunction: comparison of the ultra-short-acting β1-selective blocker landiolol with digoxin (J-Land Study).
    Nagai R; Kinugawa K; Inoue H; Atarashi H; Seino Y; Yamashita T; Shimizu W; Aiba T; Kitakaze M; Sakamoto A; Ikeda T; Imai Y; Daimon T; Fujino K; Nagano T; Okamura T; Hori M;
    Circ J; 2013; 77(4):908-16. PubMed ID: 23502991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of landiolol in patients with tachyarrhythmias and acute decompensated heart failure (ADHF): a case series.
    Ditali V; Garatti L; Morici N; Villanova L; Colombo C; Oliva F; Sacco A
    ESC Heart Fail; 2022 Feb; 9(1):766-770. PubMed ID: 34962097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of landiolol hydrochloride, an ultra-short-acting beta 1-selective blocker, on supraventricular tachycardia, atrial fibrillation and flutter after pulmonary resection.
    Nakano T; Shimizu K; Kawashima O; Kamiyoshihara M; Nagashima T; Ibe T; Takeyoshi I
    J Clin Pharm Ther; 2012 Aug; 37(4):431-5. PubMed ID: 22059486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-dependent effect of landiolol, a new ultra-short-acting β(1)-blocker, on supraventricular tachyarrhythmias in postoperative patients.
    Taenaka N; Kikawa S
    Clin Drug Investig; 2013 Jul; 33(7):505-14. PubMed ID: 23728899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of landiolol hydrochloride for prevention of atrial fibrillation after cardiac surgery in patients with left ventricular dysfunction: Prevention of Atrial Fibrillation After Cardiac Surgery With Landiolol Hydrochloride for Left Ventricular Dysfunction (PLATON) trial.
    Sezai A; Osaka S; Yaoita H; Ishii Y; Arimoto M; Hata H; Shiono M
    J Thorac Cardiovasc Surg; 2015 Oct; 150(4):957-64. PubMed ID: 26254752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel use of the ultra-short-acting intravenous β1-selective blocker landiolol for supraventricular tachyarrhythmias in patients with congestive heart failure.
    Adachi T; Sato A; Baba M; Hiraya D; Hasegawa T; Kuroki K; Hoshi T; Aonuma K
    Heart Vessels; 2014 Jul; 29(4):464-9. PubMed ID: 23801459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and Safety of Landiolol Compared to Amiodarone for the Management of Postoperative Atrial Fibrillation in Intensive Care Patients.
    Shibata SC; Uchiyama A; Ohta N; Fujino Y
    J Cardiothorac Vasc Anesth; 2016 Apr; 30(2):418-22. PubMed ID: 26703973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventive effect of intraoperative landiolol administration on atrial fibrillation after off-pump coronary artery bypass grafting.
    Osumi M; Tashiro T; Morita Y; Kamiya S; Minematsu N; Nishimi M; Wada H
    Adv Ther; 2014 Oct; 31(10):1109-17. PubMed ID: 25319249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perioperative landiolol administration reduces atrial fibrillation after cardiac surgery: A meta-analysis of randomized controlled trials.
    Sakamoto A; Hamasaki T; Kitakaze M
    Adv Ther; 2014 Apr; 31(4):440-50. PubMed ID: 24756366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.